Oral Budesonide Suspension (MB-9)
MPI-101-06
Phase 2 small_molecule completed
Quick answer
Oral Budesonide Suspension (MB-9) for Eosinophilic Esophagitis (EoE) is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Eosinophilic Esophagitis (EoE)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed